Ceres (NASDAQ:CERG)
Historical Stock Chart
From Jun 2019 to Jun 2024
Ceres Group, Inc. (NASDAQ:CERG) today announced that its
president and chief executive officer, Tom Kilian, will present at the
UBS Global Healthcare Services Conference on Tuesday, February 14, at
2:30 p.m. ET in New York City at the Grand Hyatt New York.
Investors will be able to access the audio webcast via the UBS
Investment Bank website at www.ibb.ubs.com .The direct link to the
registration page is http://event.streamx.us/event/20060213 .
Following the live webcast, a replay of the presentation will be
available until March 15, 2006. Mr. Kilian's presentation including
slides will also be available on the Ceres website at www.ceresgp.com.
About Ceres Group
Ceres Group, Inc., through its insurance subsidiaries, provides a
wide array of health and life insurance products through two primary
business segments. Ceres' Medical Segment includes major medical
health insurance for individuals, families, associations and small
businesses. The Senior Segment includes senior health, life and
annuity products for Americans age 55 and over. To help control
medical costs, Ceres also provides medical cost management services to
its insureds. Ceres' nationwide distribution channels include
independent and career agents, as well as electronic distribution
systems. Ceres is included in the Russell 3000(R) Index. For more
information, visit www.ceresgp.com.
This news release contains certain forward-looking statements with
respect to the financial condition, results of operations and business
of the company. Forward-looking statements are statements other than
historical information or statements of current condition. In light of
the risks and uncertainties inherent in all future projections, the
inclusion of forward-looking statements herein should not be regarded
as representation by the company or any other person that the
objectives or plans of the company will be achieved. Many factors
could cause actual results to differ materially from those
contemplated by such forward-looking statements, including, among
others, failure to accurately predict loss ratios and improvements in
our business, business conditions and competition in the healthcare
industry, the failure to successfully implement the business plans
(including the company's growth strategy) for the company and its
subsidiaries, failure to accurately predict claims liabilities,
ability to institute necessary rate increases, ability to develop,
market and administer new and competitive products, developments in
healthcare reform and other regulatory issues (including failure to
meet statutory capital requirements), rising healthcare costs, adverse
outcomes in litigation and related matters, failure to comply with
financial and other covenants in our loan agreement, and performance
of our reinsurers. This review of important factors should not be
construed as exhaustive. Investors and others should refer to Ceres'
filings with the Securities and Exchange Commission, including its
annual report on Form 10-K for the year ended December 31, 2004, and
its quarterly reports on Form 10-Q and other periodic filings, for a
description of the foregoing and other factors. Ceres undertakes no
obligation to update forward-looking statements to reflect events or
circumstances after the date hereof or to reflect the occurrence of
unanticipated events.